OBT076
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OBT076, covering 2025-05-09 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors [Phase 1]